CompaniesAnpac Bio

Anpac Bio

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

316

By Phase

PHASE1: 3EARLY_PHASE1: 1PHASE1/PHASE2: 1

By Status

COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT02579083
Hover over trial bars to see details

Recent Trials

NCT06444048Collaborator
Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults
PHASE1Completed
36 participants
Started: Jun 26, 2024 · Completed: Apr 11, 2025
NCT04731818Lead Sponsor
An Exploratory Study of ZB-06 as a Vaginal Contraceptive Film
EARLY_PHASE1Completed
20 participants
Started: Feb 8, 2021 · Completed: Feb 24, 2022
NCT04473690Lead Sponsor
KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers
PHASE1/PHASE2Completed
102 participants
Started: Dec 30, 2020 · Completed: Oct 14, 2022
NCT04439695Lead Sponsor
Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults
PHASE1Completed
120 participants
Started: Jun 25, 2020 · Completed: Jul 28, 2021
NCT02579083Lead Sponsor
Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV
PHASE1Completed
38 participants
Started: Jan 31, 2016 · Completed: Jul 31, 2018
Funding History (16)
8-K
Jun 26, 2024
Filing
8-K
May 23, 2024
Filing
8-K
Apr 22, 2024
Filing
8-K
Apr 2, 2024
Filing
8-K
Mar 27, 2024
Filing
8-K
Mar 25, 2024
Filing
8-K
Mar 25, 2024
Filing
8-K
Feb 16, 2024
Filing
8-K
Feb 1, 2024
Filing
8-K
Jan 29, 2024
Filing